Synthetic Genomics, Inc., a leader in designing and programming biology for function, today announced J. Craig Venter, Ph.D., has retired from his longtime position as Chairman of the company’s Board of Directors to focus on his work at the J. Craig Venter Institute. Dr. Venter will remain a Scientific Advisor to SGI.
August 14, 2018
· 3 min read